PH&T and STADA Asia announce their agreement for Latanoprost and Alfuzosin

PH&T and STADA Asia are proud to announce the successful conclusion of their agreement for Stada exclusive commercialisation of PH&T's Latanoprost and Alfuzosin.

These two products will be marketed by Stada Asia in the following Asian territories: Cambodia, Korea, Malaysia, Myanmar, Philippines, Thailand, Vietnam.